Banner image
Verdant Bioscience

Verdant Bioscience develops oil palm F1 hybrid varieties and other supporting technologies that underpin significant yield increases and productivity enhancements.

Included in the AvH investment portfolio since 2020.

42 %

Beneficial interest AvH
verdant

Key figures


$ 4.6 m

Turnover (2025)

$ -4.2 m

Net result (2025)

436

Employees (2025)

Press releases from the segment

View All
Energy & Resources

SIPEF subsidiary Tolan Tiga Indonesia signs binding letter of intent to acquire minority stakes in Indonesian Group companies

Energy & Resources

SIPEF: Disclosure of a transparency notification from Ackermans & van Haaren